AF Ablation With or Without ROX Coupler Study - Trial NCT02243891
Access comprehensive clinical trial information for NCT02243891 through Pure Global AI's free database. This Phase 4 trial is sponsored by Neil Sulke and is currently status unknown. The study focuses on Atrial Fibrillation,Hypertension. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Neil Sulke
Eastbourne General Hospital
Timeline & Enrollment
Phase 4
May 01, 2015
Oct 01, 2017
Primary Outcome
AF ablation success
Summary
The study will test the hypothesis that ablation of paroxysmal atrial fibrillation in
 hypertensive subjects is more effective when a ROX coupler is inserted concurrently.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT02243891
Non-Device Trial